ABVC BioPharma Stock (NASDAQ:ABVC)


RevenueOwnershipFinancialsChart

Previous Close

$0.66

52W Range

$0.41 - $2.45

50D Avg

$0.64

200D Avg

$0.94

Market Cap

$7.84M

Avg Vol (3M)

$128.90K

Beta

0.81

Div Yield

-

ABVC Company Profile


ABVC BioPharma, Inc., a clinical stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States. The company is developing ABV-1501, which is in Phase I/II clinical trials a combination therapy for triple negative breast cancer; ABV-1504 has completed Phase II clinical trials for major depressive disorders; ABV-1505, which is in Phase II clinical trials for attention deficit hyperactivity disorder; ABV-1703 has completed Phase I clinical trials for the treatment of pancreatic cancer; ABV-1702 has completed Phase I clinical trials to treat myelodysplastic syndromes; ABV-1601 that is in Phase I/II clinical trials for treating depression in cancer patients; and ABV-1701 Vitargus for the treatment of retinal detachment or vitreous hemorrhage. It has a co-development agreement with Rgene Corporation; and collaboration agreements with BioHopeKing Corporation and BioFirst Corporation. The company is based in Fremont, California. ABVC BioPharma, Inc. is a subsidiary of YuanGene Corporation.

Show More

Industry

Biotechnology

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

16

IPO Date

Nov 10, 2004

Website

ABVC Performance


ABVC Financial Summary


Dec 23Dec 22Dec 21
Revenue$152.43K$969.78K$355.80K
Operating Income$-8.22M$-15.11M$-11.35M
Net Income$-10.52M$-16.31M$-12.04M
EBITDA$-8.19M$-14.82M$-11.13M
Basic EPS$-2.43$-5.15$-4.80
Diluted EPS$-2.43$-5.15$-4.80

Fiscal year ends in Dec 23 | Currency in USD

Peer Comparison


TickerCompany
MGTADianthus Therapeutics, Inc.
ARDSAridis Pharmaceuticals, Inc.
NTRBNutriband Inc.
MNPRMonopar Therapeutics Inc.
SABSSAB Biotherapeutics, Inc.
KTTAPasithea Therapeutics Corp.
LGVNLongeveron Inc.
ADTXAditxt, Inc.
QNRXQuoin Pharmaceuticals, Ltd.
APTXAptinyx Inc.
EVLOEvelo Biosciences, Inc.
AKTXAkari Therapeutics, Plc
VRAXVirax Biolabs Group Limited
ELDNEledon Pharmaceuticals, Inc.
RNXTRenovoRx, Inc.
INDPIndaptus Therapeutics, Inc.
ANEBAnebulo Pharmaceuticals, Inc.
ACSTAcasti Pharma Inc.
ALRNAileron Therapeutics, Inc.
FBRXForte Biosciences, Inc.